Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV : vimarsana.com

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

Related Keywords

Kenya , Malawi , Zimbabwe , Botswana , South Africa , Fred Hutchinson Cancer Research Center , Washington , United States , Nguni , Eastern , Zambia , Uganda , Seattle , Philip Kotz , Nigel Garrett , Larry Corey , Emily Henderson , Glenda Gray , Human Services , Countermeasures Acceleration Group , National Institute Of Allergy , National Institutes Of Health , Pathogenesis Research , Program Of Research , Prevention Network Co , Department Of Health , Vaccine Trials Network , African Medical Research Council , Southern Africa , Saharan Africa , South African Medical Research Council , Trials Network , National Institute , Infectious Diseases , National Institutes , Efficacy , Iv , Accine , Llergy , Ntibodies , Ancer , Linical Trial , Nfectious Diseases , Andemic , Esearch , Ars , Ars Cov 2 , Irus ,